Clinical Trials in San Diego

Showing 14281-14300 of 14,679 trials

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

NCT00006290

The purpose of this study is to learn how changes in body build affect the lives of people taking anti-HIV medications. By learning this, a set of questions can be created to help understand how changes in body build and image affect people living with HIV infection. A set of questions used to measure body image might be useful in future HIV studies. It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications.

HIV InfectionsLipodystrophy

National Institute of Allergy and Infectious Diseases (NIAID)60 participants

San Diego, California, United States • Baltimore, Maryland, United States • Columbus, Ohio, United States +1 more locations

TERMINATEDPhase 3< 1 mile

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

NCT00133224

The primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus patients receiving docetaxel and prednisone treatment in patients with prostate cancer who no longer respond to hormone therapy, who have documented metastases with pain. Patients may have had up to one prior non-taxane chemotherapy treatment.

Prostate Cancer

Cell Genesys408 participantsStarted Jul 2005

Anchorage, Alaska, United States • Fort Smith, Arkansas, United States • Loma Linda, California, United States +112 more locations

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Docetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer Patients

Find Trials by Condition in San Diego

Safety, Tolerability and Immunogenicity of Recombinant Anthrax Vaccine Compared With Anthrax Vaccine Adsorbed

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

Study of Weekly Motexafin Gadolinium (MGd) for Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma

Optimizing Prograf® Therapy in Renal Transplant Patients

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

SLV308 for Treatment of Patients With Early Parkinson's Disease

A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis

Phase II Study of Growth Hormone in Children With Cystic Fibrosis

A Study of Women With an Early Diagnosis of Breast Cancer, Taking Celecoxib Between the Biopsy and Lumpectomy/Mastectomy

Efficacy of XP20B Following Bunionectomy Surgery

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss

A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma

Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Phase II CT-2103/Carboplatin in Ovarian Cancer

Chemoprevention of Oral Premalignant Lesions